Guobang Pharma Ltd. (605507.SS)
CNY 20.45
(0.34%)
CNY 20.45
(0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 516.76 Million | 1.01 Billion | -176.18 Million | 767.7 Million | 440.86 Million | 541.68 Million |
| Net Income | 609.97 Million | 920.62 Million | 706.22 Million | 810.28 Million | 494 Million | 483.45 Million |
| Depreciation & Amortization | 317.23 Million | 258.33 Million | 201.12 Million | 157.11 Million | 138.34 Million | 132.15 Million |
| Deferred income taxes | -1.79 Million | 20.2 Million | -5.53 Million | -755.54 Thousand | 8.23 Million | -4.41 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -433.24 Million | -183.16 Million | -1.17 Billion | -284.93 Million | -213.66 Million | -170.14 Million |
| Other non-cash items | 22.79 Million | 21.24 Million | 87.18 Million | 85.23 Million | 22.17 Million | 96.21 Million |
| Investing Cash Flow | -361.46 Million | -411.76 Million | -1.68 Billion | -365.23 Million | -307.34 Million | -146.19 Million |
| Investments in PPE | -748.44 Million | -803.11 Million | -448.04 Million | -520.15 Million | -605.18 Million | -163.24 Million |
| Acquisitions | 0.09 | 17.81 Million | 4.33 Million | 1.72 Million | -8.28 Million | -19.99 Million |
| Investment purchases | -987.48 Million | -3.15 Billion | -3.09 Billion | -421 Million | -1.23 Billion | -738.31 Million |
| Sales/Maturities of investments | 1.34 Billion | 3.53 Billion | 1.84 Billion | 575.47 Million | 1.38 Billion | 591.54 Million |
| Other Investing Activities | 24.9 Million | 1.14 | 0.18 | -1.27 Million | 158.61 Million | 183.81 Million |
| Financing Cash Flow | -45.93 Million | 366.95 Million | 1.57 Billion | -273.85 Million | -47.01 Million | -214.24 Million |
| Debt repayment | -656.5 Million | -282.99 Million | -1.11 Billion | -471.85 Million | -1.01 Billion | -891.12 Million |
| Dividends payments | -335.29 Million | -111.76 Million | -279.41 Million | -152 Million | -34.06 Million | -31.34 Million |
| Common Stock Repurchased | - | - | 22.17 Million | 5.04 Million | - | - |
| Common Stock Issuance | - | - | -22.17 Million | -5.04 Million | - | - |
| Other Financing Activities | 8.2 Million | 778.16 Million | 3.01 Billion | 386.03 Million | 997.88 Million | 708.23 Million |
| Accounts receivables | -929.35 Million | -255.52 Million | -841.8 Million | -51.43 Million | 45.9 Million | 233.36 Million |
| Accounts payables | 488.7 Million | 179.69 Million | 48.23 Million | -75.52 Million | -274.02 Million | -105.8 Million |
| Inventory | 9.2 Million | -127.53 Million | -371.61 Million | -157.22 Million | 6.21 Million | -293.27 Million |
| Other working capital | -1.79 Million | 20.2 Million | -5.53 Million | -755.54 Thousand | 8.23 Million | 123.13 Million |
| Cash at beginning of period | 1.58 Billion | 573.66 Million | 879.09 Million | 783.09 Million | 691.14 Million | 501.58 Million |
| Cash at end of period | 1.7 Billion | 1.58 Billion | 573.66 Million | 879.09 Million | 783.09 Million | 691.14 Million |
| Capital Expenditure | -748.44 Million | -803.11 Million | -448.04 Million | -520.15 Million | -605.18 Million | -163.24 Million |
| Effect of forex changes on cash | 10.7 Million | 35.26 Million | -9.93 Million | -32.61 Million | 5.44 Million | 8.31 Million |
| Net cash flow / Change in cash | 120.06 Million | 1 Billion | -305.43 Million | 96 Million | 91.94 Million | 189.56 Million |
| Free Cash Flow | -231.68 Million | 213.91 Million | -624.22 Million | 247.54 Million | -164.31 Million | 378.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 174.28 Million | 205.86 Million | 198.73 Million | 609.97 Million | 123.39 Million | 131.6 Million |
| Depreciation & Amortization | - | 102.9 Million | 102.9 Million | 317.23 Million | 83.25 Million | -155.09 Million |
| Deferred income taxes | - | - | - | -1.79 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -414.82 Million | - | -433.24 Million | -922.62 Million | 598.46 Million |
| Other non-cash items | 108.99 Million | -273.83 Million | -277.84 Million | 22.79 Million | 1.22 Billion | -596.05 Million |
| Investing Cash Flow | -185.86 Million | -219.73 Million | 4.38 Million | -361.46 Million | -448.84 Million | -19.47 Million |
| Investments in PPE | -32.34 Million | -44.98 Million | -126.93 Million | -748.44 Million | -272.18 Million | -135.33 Million |
| Acquisitions | - | 50 Thousand | 530 Thousand | 0.09 | 0.86 | 0.81 |
| Investment purchases | -1.13 Billion | -327.59 Million | -61.88 Million | -987.48 Million | -179.04 Million | -255.52 Million |
| Sales/Maturities of investments | 986.48 Million | 152.79 Million | 193.19 Million | 1.34 Billion | -22.51 Million | 371.38 Million |
| Other Investing Activities | - | -174.79 Million | -529.99 Thousand | 24.9 Million | 24.9 Million | - |
| Financing Cash Flow | 17.37 Million | -242.57 Million | 74.11 Million | -45.93 Million | 118.37 Million | -28.57 Million |
| Debt repayment | -71.88 Million | -3.7 Million | -94.5 Million | -656.5 Million | -119.68 Million | -111.57 Million |
| Dividends payments | -6.37 Million | -174.33 Million | -7.32 Million | -335.29 Million | -335.29 Million | -6.29 Million |
| Common Stock Repurchased | - | -99.52 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 95.63 Million | -246.27 Million | -27.05 Million | 8.2 Million | 325.15 Million | 89.3 Million |
| Accounts receivables | - | -404.98 Million | - | -929.35 Million | -929.35 Million | 611.59 Million |
| Accounts payables | - | - | - | 488.7 Million | - | -1.13 Million |
| Inventory | - | -11.88 Million | - | 9.2 Million | 9.2 Million | -13.13 Million |
| Other working capital | - | 2.04 Million | - | -1.79 Million | -2.46 Million | 1.13 Million |
| Cash at beginning of period | 1.08 Billion | 2.03 Billion | 1.7 Billion | 1.58 Billion | 1.52 Billion | 1.58 Billion |
| Cash at end of period | 1.19 Billion | 1.34 Billion | 1.7 Billion | 1.7 Billion | 1.7 Billion | 1.52 Billion |
| Capital Expenditure | -32.34 Million | -44.98 Million | -126.93 Million | -748.44 Million | -272.18 Million | -135.33 Million |
| Effect of forex changes on cash | -2.32 Million | 10.31 Million | 6.14 Million | 10.7 Million | 2.61 Million | 3.9 Million |
| Net cash flow / Change in cash | 112.04 Million | -697.61 Million | 5.52 Million | 120.06 Million | 178.01 Million | -65.23 Million |
| Free Cash Flow | 250.93 Million | -215.85 Million | -206.04 Million | -231.68 Million | 233.67 Million | -156.41 Million |
600063
BLBLF
ENGNW
0104
ASHOKRE
DAULAT